Global Drug Abuse Screening Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Drug Abuse Screening market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Drug Abuse Screening market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Drug Abuse Screening market size and forecasts, in consumption value ($ Million), 2020-2031
Global Drug Abuse Screening market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Drug Abuse Screening market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Drug Abuse Screening market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Drug Abuse Screening
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Drug Abuse Screening market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Bio-Rad Laboratories, Clinical Reference Laboratory, Laboratory Corporation of America Holdings, Legacy Medical Services, LGC Group, Mayo Clinic Laboratories, Millennium Health, Omega Laboratories, Precision Diagnostics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Drug Abuse Screening market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Drug Abuse Screening product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Drug Abuse Screening, with revenue, gross margin, and global market share of Drug Abuse Screening from 2020 to 2025.
Chapter 3, the Drug Abuse Screening competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Drug Abuse Screening market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drug Abuse Screening.
Chapter 13, to describe Drug Abuse Screening research findings and conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Drug Abuse Screening market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Drug Abuse Screening market size and forecasts, in consumption value ($ Million), 2020-2031
Global Drug Abuse Screening market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Drug Abuse Screening market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Drug Abuse Screening market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Drug Abuse Screening
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Drug Abuse Screening market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Bio-Rad Laboratories, Clinical Reference Laboratory, Laboratory Corporation of America Holdings, Legacy Medical Services, LGC Group, Mayo Clinic Laboratories, Millennium Health, Omega Laboratories, Precision Diagnostics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Drug Abuse Screening market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Urine Sample
- Breath Sample
- Oral Fluid Sample
- Hair Sample
- Drug Testing Laboratories
- Hospital
- Others
- Abbott Laboratories
- Bio-Rad Laboratories
- Clinical Reference Laboratory
- Laboratory Corporation of America Holdings
- Legacy Medical Services
- LGC Group
- Mayo Clinic Laboratories
- Millennium Health
- Omega Laboratories
- Precision Diagnostics
- Psychemedics
- Quest Diagnostics
- Sonic Healthcare
- United States Drug Testing Laboratories
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Drug Abuse Screening product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Drug Abuse Screening, with revenue, gross margin, and global market share of Drug Abuse Screening from 2020 to 2025.
Chapter 3, the Drug Abuse Screening competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Drug Abuse Screening market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drug Abuse Screening.
Chapter 13, to describe Drug Abuse Screening research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Drug Abuse Screening by Type
1.3.1 Overview: Global Drug Abuse Screening Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Drug Abuse Screening Consumption Value Market Share by Type in 2024
1.3.3 Urine Sample
1.3.4 Breath Sample
1.3.5 Oral Fluid Sample
1.3.6 Hair Sample
1.4 Global Drug Abuse Screening Market by Application
1.4.1 Overview: Global Drug Abuse Screening Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Drug Testing Laboratories
1.4.3 Hospital
1.4.4 Others
1.5 Global Drug Abuse Screening Market Size & Forecast
1.6 Global Drug Abuse Screening Market Size and Forecast by Region
1.6.1 Global Drug Abuse Screening Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Drug Abuse Screening Market Size by Region, (2020-2031)
1.6.3 North America Drug Abuse Screening Market Size and Prospect (2020-2031)
1.6.4 Europe Drug Abuse Screening Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Drug Abuse Screening Market Size and Prospect (2020-2031)
1.6.6 South America Drug Abuse Screening Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Drug Abuse Screening Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Drug Abuse Screening Product and Solutions
2.1.4 Abbott Laboratories Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Bio-Rad Laboratories
2.2.1 Bio-Rad Laboratories Details
2.2.2 Bio-Rad Laboratories Major Business
2.2.3 Bio-Rad Laboratories Drug Abuse Screening Product and Solutions
2.2.4 Bio-Rad Laboratories Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.3 Clinical Reference Laboratory
2.3.1 Clinical Reference Laboratory Details
2.3.2 Clinical Reference Laboratory Major Business
2.3.3 Clinical Reference Laboratory Drug Abuse Screening Product and Solutions
2.3.4 Clinical Reference Laboratory Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Clinical Reference Laboratory Recent Developments and Future Plans
2.4 Laboratory Corporation of America Holdings
2.4.1 Laboratory Corporation of America Holdings Details
2.4.2 Laboratory Corporation of America Holdings Major Business
2.4.3 Laboratory Corporation of America Holdings Drug Abuse Screening Product and Solutions
2.4.4 Laboratory Corporation of America Holdings Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans
2.5 Legacy Medical Services
2.5.1 Legacy Medical Services Details
2.5.2 Legacy Medical Services Major Business
2.5.3 Legacy Medical Services Drug Abuse Screening Product and Solutions
2.5.4 Legacy Medical Services Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Legacy Medical Services Recent Developments and Future Plans
2.6 LGC Group
2.6.1 LGC Group Details
2.6.2 LGC Group Major Business
2.6.3 LGC Group Drug Abuse Screening Product and Solutions
2.6.4 LGC Group Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 LGC Group Recent Developments and Future Plans
2.7 Mayo Clinic Laboratories
2.7.1 Mayo Clinic Laboratories Details
2.7.2 Mayo Clinic Laboratories Major Business
2.7.3 Mayo Clinic Laboratories Drug Abuse Screening Product and Solutions
2.7.4 Mayo Clinic Laboratories Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Mayo Clinic Laboratories Recent Developments and Future Plans
2.8 Millennium Health
2.8.1 Millennium Health Details
2.8.2 Millennium Health Major Business
2.8.3 Millennium Health Drug Abuse Screening Product and Solutions
2.8.4 Millennium Health Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Millennium Health Recent Developments and Future Plans
2.9 Omega Laboratories
2.9.1 Omega Laboratories Details
2.9.2 Omega Laboratories Major Business
2.9.3 Omega Laboratories Drug Abuse Screening Product and Solutions
2.9.4 Omega Laboratories Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Omega Laboratories Recent Developments and Future Plans
2.10 Precision Diagnostics
2.10.1 Precision Diagnostics Details
2.10.2 Precision Diagnostics Major Business
2.10.3 Precision Diagnostics Drug Abuse Screening Product and Solutions
2.10.4 Precision Diagnostics Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Precision Diagnostics Recent Developments and Future Plans
2.11 Psychemedics
2.11.1 Psychemedics Details
2.11.2 Psychemedics Major Business
2.11.3 Psychemedics Drug Abuse Screening Product and Solutions
2.11.4 Psychemedics Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Psychemedics Recent Developments and Future Plans
2.12 Quest Diagnostics
2.12.1 Quest Diagnostics Details
2.12.2 Quest Diagnostics Major Business
2.12.3 Quest Diagnostics Drug Abuse Screening Product and Solutions
2.12.4 Quest Diagnostics Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Quest Diagnostics Recent Developments and Future Plans
2.13 Sonic Healthcare
2.13.1 Sonic Healthcare Details
2.13.2 Sonic Healthcare Major Business
2.13.3 Sonic Healthcare Drug Abuse Screening Product and Solutions
2.13.4 Sonic Healthcare Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Sonic Healthcare Recent Developments and Future Plans
2.14 United States Drug Testing Laboratories
2.14.1 United States Drug Testing Laboratories Details
2.14.2 United States Drug Testing Laboratories Major Business
2.14.3 United States Drug Testing Laboratories Drug Abuse Screening Product and Solutions
2.14.4 United States Drug Testing Laboratories Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 United States Drug Testing Laboratories Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Drug Abuse Screening Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Drug Abuse Screening by Company Revenue
3.2.2 Top 3 Drug Abuse Screening Players Market Share in 2024
3.2.3 Top 6 Drug Abuse Screening Players Market Share in 2024
3.3 Drug Abuse Screening Market: Overall Company Footprint Analysis
3.3.1 Drug Abuse Screening Market: Region Footprint
3.3.2 Drug Abuse Screening Market: Company Product Type Footprint
3.3.3 Drug Abuse Screening Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Drug Abuse Screening Consumption Value and Market Share by Type (2020-2025)
4.2 Global Drug Abuse Screening Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Drug Abuse Screening Consumption Value Market Share by Application (2020-2025)
5.2 Global Drug Abuse Screening Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Drug Abuse Screening Consumption Value by Type (2020-2031)
6.2 North America Drug Abuse Screening Market Size by Application (2020-2031)
6.3 North America Drug Abuse Screening Market Size by Country
6.3.1 North America Drug Abuse Screening Consumption Value by Country (2020-2031)
6.3.2 United States Drug Abuse Screening Market Size and Forecast (2020-2031)
6.3.3 Canada Drug Abuse Screening Market Size and Forecast (2020-2031)
6.3.4 Mexico Drug Abuse Screening Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Drug Abuse Screening Consumption Value by Type (2020-2031)
7.2 Europe Drug Abuse Screening Consumption Value by Application (2020-2031)
7.3 Europe Drug Abuse Screening Market Size by Country
7.3.1 Europe Drug Abuse Screening Consumption Value by Country (2020-2031)
7.3.2 Germany Drug Abuse Screening Market Size and Forecast (2020-2031)
7.3.3 France Drug Abuse Screening Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Drug Abuse Screening Market Size and Forecast (2020-2031)
7.3.5 Russia Drug Abuse Screening Market Size and Forecast (2020-2031)
7.3.6 Italy Drug Abuse Screening Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Drug Abuse Screening Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Drug Abuse Screening Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Drug Abuse Screening Market Size by Region
8.3.1 Asia-Pacific Drug Abuse Screening Consumption Value by Region (2020-2031)
8.3.2 China Drug Abuse Screening Market Size and Forecast (2020-2031)
8.3.3 Japan Drug Abuse Screening Market Size and Forecast (2020-2031)
8.3.4 South Korea Drug Abuse Screening Market Size and Forecast (2020-2031)
8.3.5 India Drug Abuse Screening Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Drug Abuse Screening Market Size and Forecast (2020-2031)
8.3.7 Australia Drug Abuse Screening Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Drug Abuse Screening Consumption Value by Type (2020-2031)
9.2 South America Drug Abuse Screening Consumption Value by Application (2020-2031)
9.3 South America Drug Abuse Screening Market Size by Country
9.3.1 South America Drug Abuse Screening Consumption Value by Country (2020-2031)
9.3.2 Brazil Drug Abuse Screening Market Size and Forecast (2020-2031)
9.3.3 Argentina Drug Abuse Screening Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Drug Abuse Screening Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Drug Abuse Screening Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Drug Abuse Screening Market Size by Country
10.3.1 Middle East & Africa Drug Abuse Screening Consumption Value by Country (2020-2031)
10.3.2 Turkey Drug Abuse Screening Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Drug Abuse Screening Market Size and Forecast (2020-2031)
10.3.4 UAE Drug Abuse Screening Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Drug Abuse Screening Market Drivers
11.2 Drug Abuse Screening Market Restraints
11.3 Drug Abuse Screening Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Drug Abuse Screening Industry Chain
12.2 Drug Abuse Screening Upstream Analysis
12.3 Drug Abuse Screening Midstream Analysis
12.4 Drug Abuse Screening Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Drug Abuse Screening by Type
1.3.1 Overview: Global Drug Abuse Screening Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Drug Abuse Screening Consumption Value Market Share by Type in 2024
1.3.3 Urine Sample
1.3.4 Breath Sample
1.3.5 Oral Fluid Sample
1.3.6 Hair Sample
1.4 Global Drug Abuse Screening Market by Application
1.4.1 Overview: Global Drug Abuse Screening Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Drug Testing Laboratories
1.4.3 Hospital
1.4.4 Others
1.5 Global Drug Abuse Screening Market Size & Forecast
1.6 Global Drug Abuse Screening Market Size and Forecast by Region
1.6.1 Global Drug Abuse Screening Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Drug Abuse Screening Market Size by Region, (2020-2031)
1.6.3 North America Drug Abuse Screening Market Size and Prospect (2020-2031)
1.6.4 Europe Drug Abuse Screening Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Drug Abuse Screening Market Size and Prospect (2020-2031)
1.6.6 South America Drug Abuse Screening Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Drug Abuse Screening Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Drug Abuse Screening Product and Solutions
2.1.4 Abbott Laboratories Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Bio-Rad Laboratories
2.2.1 Bio-Rad Laboratories Details
2.2.2 Bio-Rad Laboratories Major Business
2.2.3 Bio-Rad Laboratories Drug Abuse Screening Product and Solutions
2.2.4 Bio-Rad Laboratories Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.3 Clinical Reference Laboratory
2.3.1 Clinical Reference Laboratory Details
2.3.2 Clinical Reference Laboratory Major Business
2.3.3 Clinical Reference Laboratory Drug Abuse Screening Product and Solutions
2.3.4 Clinical Reference Laboratory Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Clinical Reference Laboratory Recent Developments and Future Plans
2.4 Laboratory Corporation of America Holdings
2.4.1 Laboratory Corporation of America Holdings Details
2.4.2 Laboratory Corporation of America Holdings Major Business
2.4.3 Laboratory Corporation of America Holdings Drug Abuse Screening Product and Solutions
2.4.4 Laboratory Corporation of America Holdings Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans
2.5 Legacy Medical Services
2.5.1 Legacy Medical Services Details
2.5.2 Legacy Medical Services Major Business
2.5.3 Legacy Medical Services Drug Abuse Screening Product and Solutions
2.5.4 Legacy Medical Services Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Legacy Medical Services Recent Developments and Future Plans
2.6 LGC Group
2.6.1 LGC Group Details
2.6.2 LGC Group Major Business
2.6.3 LGC Group Drug Abuse Screening Product and Solutions
2.6.4 LGC Group Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 LGC Group Recent Developments and Future Plans
2.7 Mayo Clinic Laboratories
2.7.1 Mayo Clinic Laboratories Details
2.7.2 Mayo Clinic Laboratories Major Business
2.7.3 Mayo Clinic Laboratories Drug Abuse Screening Product and Solutions
2.7.4 Mayo Clinic Laboratories Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Mayo Clinic Laboratories Recent Developments and Future Plans
2.8 Millennium Health
2.8.1 Millennium Health Details
2.8.2 Millennium Health Major Business
2.8.3 Millennium Health Drug Abuse Screening Product and Solutions
2.8.4 Millennium Health Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Millennium Health Recent Developments and Future Plans
2.9 Omega Laboratories
2.9.1 Omega Laboratories Details
2.9.2 Omega Laboratories Major Business
2.9.3 Omega Laboratories Drug Abuse Screening Product and Solutions
2.9.4 Omega Laboratories Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Omega Laboratories Recent Developments and Future Plans
2.10 Precision Diagnostics
2.10.1 Precision Diagnostics Details
2.10.2 Precision Diagnostics Major Business
2.10.3 Precision Diagnostics Drug Abuse Screening Product and Solutions
2.10.4 Precision Diagnostics Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Precision Diagnostics Recent Developments and Future Plans
2.11 Psychemedics
2.11.1 Psychemedics Details
2.11.2 Psychemedics Major Business
2.11.3 Psychemedics Drug Abuse Screening Product and Solutions
2.11.4 Psychemedics Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Psychemedics Recent Developments and Future Plans
2.12 Quest Diagnostics
2.12.1 Quest Diagnostics Details
2.12.2 Quest Diagnostics Major Business
2.12.3 Quest Diagnostics Drug Abuse Screening Product and Solutions
2.12.4 Quest Diagnostics Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Quest Diagnostics Recent Developments and Future Plans
2.13 Sonic Healthcare
2.13.1 Sonic Healthcare Details
2.13.2 Sonic Healthcare Major Business
2.13.3 Sonic Healthcare Drug Abuse Screening Product and Solutions
2.13.4 Sonic Healthcare Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Sonic Healthcare Recent Developments and Future Plans
2.14 United States Drug Testing Laboratories
2.14.1 United States Drug Testing Laboratories Details
2.14.2 United States Drug Testing Laboratories Major Business
2.14.3 United States Drug Testing Laboratories Drug Abuse Screening Product and Solutions
2.14.4 United States Drug Testing Laboratories Drug Abuse Screening Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 United States Drug Testing Laboratories Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Drug Abuse Screening Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Drug Abuse Screening by Company Revenue
3.2.2 Top 3 Drug Abuse Screening Players Market Share in 2024
3.2.3 Top 6 Drug Abuse Screening Players Market Share in 2024
3.3 Drug Abuse Screening Market: Overall Company Footprint Analysis
3.3.1 Drug Abuse Screening Market: Region Footprint
3.3.2 Drug Abuse Screening Market: Company Product Type Footprint
3.3.3 Drug Abuse Screening Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Drug Abuse Screening Consumption Value and Market Share by Type (2020-2025)
4.2 Global Drug Abuse Screening Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Drug Abuse Screening Consumption Value Market Share by Application (2020-2025)
5.2 Global Drug Abuse Screening Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Drug Abuse Screening Consumption Value by Type (2020-2031)
6.2 North America Drug Abuse Screening Market Size by Application (2020-2031)
6.3 North America Drug Abuse Screening Market Size by Country
6.3.1 North America Drug Abuse Screening Consumption Value by Country (2020-2031)
6.3.2 United States Drug Abuse Screening Market Size and Forecast (2020-2031)
6.3.3 Canada Drug Abuse Screening Market Size and Forecast (2020-2031)
6.3.4 Mexico Drug Abuse Screening Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Drug Abuse Screening Consumption Value by Type (2020-2031)
7.2 Europe Drug Abuse Screening Consumption Value by Application (2020-2031)
7.3 Europe Drug Abuse Screening Market Size by Country
7.3.1 Europe Drug Abuse Screening Consumption Value by Country (2020-2031)
7.3.2 Germany Drug Abuse Screening Market Size and Forecast (2020-2031)
7.3.3 France Drug Abuse Screening Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Drug Abuse Screening Market Size and Forecast (2020-2031)
7.3.5 Russia Drug Abuse Screening Market Size and Forecast (2020-2031)
7.3.6 Italy Drug Abuse Screening Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Drug Abuse Screening Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Drug Abuse Screening Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Drug Abuse Screening Market Size by Region
8.3.1 Asia-Pacific Drug Abuse Screening Consumption Value by Region (2020-2031)
8.3.2 China Drug Abuse Screening Market Size and Forecast (2020-2031)
8.3.3 Japan Drug Abuse Screening Market Size and Forecast (2020-2031)
8.3.4 South Korea Drug Abuse Screening Market Size and Forecast (2020-2031)
8.3.5 India Drug Abuse Screening Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Drug Abuse Screening Market Size and Forecast (2020-2031)
8.3.7 Australia Drug Abuse Screening Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Drug Abuse Screening Consumption Value by Type (2020-2031)
9.2 South America Drug Abuse Screening Consumption Value by Application (2020-2031)
9.3 South America Drug Abuse Screening Market Size by Country
9.3.1 South America Drug Abuse Screening Consumption Value by Country (2020-2031)
9.3.2 Brazil Drug Abuse Screening Market Size and Forecast (2020-2031)
9.3.3 Argentina Drug Abuse Screening Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Drug Abuse Screening Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Drug Abuse Screening Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Drug Abuse Screening Market Size by Country
10.3.1 Middle East & Africa Drug Abuse Screening Consumption Value by Country (2020-2031)
10.3.2 Turkey Drug Abuse Screening Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Drug Abuse Screening Market Size and Forecast (2020-2031)
10.3.4 UAE Drug Abuse Screening Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Drug Abuse Screening Market Drivers
11.2 Drug Abuse Screening Market Restraints
11.3 Drug Abuse Screening Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Drug Abuse Screening Industry Chain
12.2 Drug Abuse Screening Upstream Analysis
12.3 Drug Abuse Screening Midstream Analysis
12.4 Drug Abuse Screening Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF FIGURES
Table 1. Global Drug Abuse Screening Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Drug Abuse Screening Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Drug Abuse Screening Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Drug Abuse Screening Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Abbott Laboratories Company Information, Head Office, and Major Competitors
Table 6. Abbott Laboratories Major Business
Table 7. Abbott Laboratories Drug Abuse Screening Product and Solutions
Table 8. Abbott Laboratories Drug Abuse Screening Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Abbott Laboratories Recent Developments and Future Plans
Table 10. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 11. Bio-Rad Laboratories Major Business
Table 12. Bio-Rad Laboratories Drug Abuse Screening Product and Solutions
Table 13. Bio-Rad Laboratories Drug Abuse Screening Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Bio-Rad Laboratories Recent Developments and Future Plans
Table 15. Clinical Reference Laboratory Company Information, Head Office, and Major Competitors
Table 16. Clinical Reference Laboratory Major Business
Table 17. Clinical Reference Laboratory Drug Abuse Screening Product and Solutions
Table 18. Clinical Reference Laboratory Drug Abuse Screening Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Laboratory Corporation of America Holdings Company Information, Head Office, and Major Competitors
Table 20. Laboratory Corporation of America Holdings Major Business
Table 21. Laboratory Corporation of America Holdings Drug Abuse Screening Product and Solutions
Table 22. Laboratory Corporation of America Holdings Drug Abuse Screening Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Laboratory Corporation of America Holdings Recent Developments and Future Plans
Table 24. Legacy Medical Services Company Information, Head Office, and Major Competitors
Table 25. Legacy Medical Services Major Business
Table 26. Legacy Medical Services Drug Abuse Screening Product and Solutions
Table 27. Legacy Medical Services Drug Abuse Screening Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Legacy Medical Services Recent Developments and Future Plans
Table 29. LGC Group Company Information, Head Office, and Major Competitors
Table 30. LGC Group Major Business
Table 31. LGC Group Drug Abuse Screening Product and Solutions
Table 32. LGC Group Drug Abuse Screening Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. LGC Group Recent Developments and Future Plans
Table 34. Mayo Clinic Laboratories Company Information, Head Office, and Major Competitors
Table 35. Mayo Clinic Laboratories Major Business
Table 36. Mayo Clinic Laboratories Drug Abuse Screening Product and Solutions
Table 37. Mayo Clinic Laboratories Drug Abuse Screening Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Mayo Clinic Laboratories Recent Developments and Future Plans
Table 39. Millennium Health Company Information, Head Office, and Major Competitors
Table 40. Millennium Health Major Business
Table 41. Millennium Health Drug Abuse Screening Product and Solutions
Table 42. Millennium Health Drug Abuse Screening Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Millennium Health Recent Developments and Future Plans
Table 44. Omega Laboratories Company Information, Head Office, and Major Competitors
Table 45. Omega Laboratories Major Business
Table 46. Omega Laboratories Drug Abuse Screening Product and Solutions
Table 47. Omega Laboratories Drug Abuse Screening Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Omega Laboratories Recent Developments and Future Plans
Table 49. Precision Diagnostics Company Information, Head Office, and Major Competitors
Table 50. Precision Diagnostics Major Business
Table 51. Precision Diagnostics Drug Abuse Screening Product and Solutions
Table 52. Precision Diagnostics Drug Abuse Screening Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Precision Diagnostics Recent Developments and Future Plans
Table 54. Psychemedics Company Information, Head Office, and Major Competitors
Table 55. Psychemedics Major Business
Table 56. Psychemedics Drug Abuse Screening Product and Solutions
Table 57. Psychemedics Drug Abuse Screening Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Psychemedics Recent Developments and Future Plans
Table 59. Quest Diagnostics Company Information, Head Office, and Major Competitors
Table 60. Quest Diagnostics Major Business
Table 61. Quest Diagnostics Drug Abuse Screening Product and Solutions
Table 62. Quest Diagnostics Drug Abuse Screening Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Quest Diagnostics Recent Developments and Future Plans
Table 64. Sonic Healthcare Company Information, Head Office, and Major Competitors
Table 65. Sonic Healthcare Major Business
Table 66. Sonic Healthcare Drug Abuse Screening Product and Solutions
Table 67. Sonic Healthcare Drug Abuse Screening Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Sonic Healthcare Recent Developments and Future Plans
Table 69. United States Drug Testing Laboratories Company Information, Head Office, and Major Competitors
Table 70. United States Drug Testing Laboratories Major Business
Table 71. United States Drug Testing Laboratories Drug Abuse Screening Product and Solutions
Table 72. United States Drug Testing Laboratories Drug Abuse Screening Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. United States Drug Testing Laboratories Recent Developments and Future Plans
Table 74. Global Drug Abuse Screening Revenue (USD Million) by Players (2020-2025)
Table 75. Global Drug Abuse Screening Revenue Share by Players (2020-2025)
Table 76. Breakdown of Drug Abuse Screening by Company Type (Tier 1, Tier 2, and Tier 3)
Table 77. Market Position of Players in Drug Abuse Screening, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 78. Head Office of Key Drug Abuse Screening Players
Table 79. Drug Abuse Screening Market: Company Product Type Footprint
Table 80. Drug Abuse Screening Market: Company Product Application Footprint
Table 81. Drug Abuse Screening New Market Entrants and Barriers to Market Entry
Table 82. Drug Abuse Screening Mergers, Acquisition, Agreements, and Collaborations
Table 83. Global Drug Abuse Screening Consumption Value (USD Million) by Type (2020-2025)
Table 84. Global Drug Abuse Screening Consumption Value Share by Type (2020-2025)
Table 85. Global Drug Abuse Screening Consumption Value Forecast by Type (2026-2031)
Table 86. Global Drug Abuse Screening Consumption Value by Application (2020-2025)
Table 87. Global Drug Abuse Screening Consumption Value Forecast by Application (2026-2031)
Table 88. North America Drug Abuse Screening Consumption Value by Type (2020-2025) & (USD Million)
Table 89. North America Drug Abuse Screening Consumption Value by Type (2026-2031) & (USD Million)
Table 90. North America Drug Abuse Screening Consumption Value by Application (2020-2025) & (USD Million)
Table 91. North America Drug Abuse Screening Consumption Value by Application (2026-2031) & (USD Million)
Table 92. North America Drug Abuse Screening Consumption Value by Country (2020-2025) & (USD Million)
Table 93. North America Drug Abuse Screening Consumption Value by Country (2026-2031) & (USD Million)
Table 94. Europe Drug Abuse Screening Consumption Value by Type (2020-2025) & (USD Million)
Table 95. Europe Drug Abuse Screening Consumption Value by Type (2026-2031) & (USD Million)
Table 96. Europe Drug Abuse Screening Consumption Value by Application (2020-2025) & (USD Million)
Table 97. Europe Drug Abuse Screening Consumption Value by Application (2026-2031) & (USD Million)
Table 98. Europe Drug Abuse Screening Consumption Value by Country (2020-2025) & (USD Million)
Table 99. Europe Drug Abuse Screening Consumption Value by Country (2026-2031) & (USD Million)
Table 100. Asia-Pacific Drug Abuse Screening Consumption Value by Type (2020-2025) & (USD Million)
Table 101. Asia-Pacific Drug Abuse Screening Consumption Value by Type (2026-2031) & (USD Million)
Table 102. Asia-Pacific Drug Abuse Screening Consumption Value by Application (2020-2025) & (USD Million)
Table 103. Asia-Pacific Drug Abuse Screening Consumption Value by Application (2026-2031) & (USD Million)
Table 104. Asia-Pacific Drug Abuse Screening Consumption Value by Region (2020-2025) & (USD Million)
Table 105. Asia-Pacific Drug Abuse Screening Consumption Value by Region (2026-2031) & (USD Million)
Table 106. South America Drug Abuse Screening Consumption Value by Type (2020-2025) & (USD Million)
Table 107. South America Drug Abuse Screening Consumption Value by Type (2026-2031) & (USD Million)
Table 108. South America Drug Abuse Screening Consumption Value by Application (2020-2025) & (USD Million)
Table 109. South America Drug Abuse Screening Consumption Value by Application (2026-2031) & (USD Million)
Table 110. South America Drug Abuse Screening Consumption Value by Country (2020-2025) & (USD Million)
Table 111. South America Drug Abuse Screening Consumption Value by Country (2026-2031) & (USD Million)
Table 112. Middle East & Africa Drug Abuse Screening Consumption Value by Type (2020-2025) & (USD Million)
Table 113. Middle East & Africa Drug Abuse Screening Consumption Value by Type (2026-2031) & (USD Million)
Table 114. Middle East & Africa Drug Abuse Screening Consumption Value by Application (2020-2025) & (USD Million)
Table 115. Middle East & Africa Drug Abuse Screening Consumption Value by Application (2026-2031) & (USD Million)
Table 116. Middle East & Africa Drug Abuse Screening Consumption Value by Country (2020-2025) & (USD Million)
Table 117. Middle East & Africa Drug Abuse Screening Consumption Value by Country (2026-2031) & (USD Million)
Table 118. Global Key Players of Drug Abuse Screening Upstream (Raw Materials)
Table 119. Global Drug Abuse Screening Typical Customers
LIST OF FIGURES
Figure 1. Drug Abuse Screening Picture
Figure 2. Global Drug Abuse Screening Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Drug Abuse Screening Consumption Value Market Share by Type in 2024
Figure 4. Urine Sample
Figure 5. Breath Sample
Figure 6. Oral Fluid Sample
Figure 7. Hair Sample
Figure 8. Global Drug Abuse Screening Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Drug Abuse Screening Consumption Value Market Share by Application in 2024
Figure 10. Drug Testing Laboratories Picture
Figure 11. Hospital Picture
Figure 12. Others Picture
Figure 13. Global Drug Abuse Screening Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global Drug Abuse Screening Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 15. Global Market Drug Abuse Screening Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 16. Global Drug Abuse Screening Consumption Value Market Share by Region (2020-2031)
Figure 17. Global Drug Abuse Screening Consumption Value Market Share by Region in 2024
Figure 18. North America Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 19. Europe Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 20. Asia-Pacific Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 21. South America Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 22. Middle East & Africa Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 23. Company Three Recent Developments and Future Plans
Figure 24. Global Drug Abuse Screening Revenue Share by Players in 2024
Figure 25. Drug Abuse Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 26. Market Share of Drug Abuse Screening by Player Revenue in 2024
Figure 27. Top 3 Drug Abuse Screening Players Market Share in 2024
Figure 28. Top 6 Drug Abuse Screening Players Market Share in 2024
Figure 29. Global Drug Abuse Screening Consumption Value Share by Type (2020-2025)
Figure 30. Global Drug Abuse Screening Market Share Forecast by Type (2026-2031)
Figure 31. Global Drug Abuse Screening Consumption Value Share by Application (2020-2025)
Figure 32. Global Drug Abuse Screening Market Share Forecast by Application (2026-2031)
Figure 33. North America Drug Abuse Screening Consumption Value Market Share by Type (2020-2031)
Figure 34. North America Drug Abuse Screening Consumption Value Market Share by Application (2020-2031)
Figure 35. North America Drug Abuse Screening Consumption Value Market Share by Country (2020-2031)
Figure 36. United States Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 37. Canada Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 38. Mexico Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 39. Europe Drug Abuse Screening Consumption Value Market Share by Type (2020-2031)
Figure 40. Europe Drug Abuse Screening Consumption Value Market Share by Application (2020-2031)
Figure 41. Europe Drug Abuse Screening Consumption Value Market Share by Country (2020-2031)
Figure 42. Germany Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 43. France Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 44. United Kingdom Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 45. Russia Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 46. Italy Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 47. Asia-Pacific Drug Abuse Screening Consumption Value Market Share by Type (2020-2031)
Figure 48. Asia-Pacific Drug Abuse Screening Consumption Value Market Share by Application (2020-2031)
Figure 49. Asia-Pacific Drug Abuse Screening Consumption Value Market Share by Region (2020-2031)
Figure 50. China Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 51. Japan Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 52. South Korea Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 53. India Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 54. Southeast Asia Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 55. Australia Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 56. South America Drug Abuse Screening Consumption Value Market Share by Type (2020-2031)
Figure 57. South America Drug Abuse Screening Consumption Value Market Share by Application (2020-2031)
Figure 58. South America Drug Abuse Screening Consumption Value Market Share by Country (2020-2031)
Figure 59. Brazil Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 60. Argentina Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 61. Middle East & Africa Drug Abuse Screening Consumption Value Market Share by Type (2020-2031)
Figure 62. Middle East & Africa Drug Abuse Screening Consumption Value Market Share by Application (2020-2031)
Figure 63. Middle East & Africa Drug Abuse Screening Consumption Value Market Share by Country (2020-2031)
Figure 64. Turkey Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 65. Saudi Arabia Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 66. UAE Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 67. Drug Abuse Screening Market Drivers
Figure 68. Drug Abuse Screening Market Restraints
Figure 69. Drug Abuse Screening Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Drug Abuse Screening Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Table 1. Global Drug Abuse Screening Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Drug Abuse Screening Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Drug Abuse Screening Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Drug Abuse Screening Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Abbott Laboratories Company Information, Head Office, and Major Competitors
Table 6. Abbott Laboratories Major Business
Table 7. Abbott Laboratories Drug Abuse Screening Product and Solutions
Table 8. Abbott Laboratories Drug Abuse Screening Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Abbott Laboratories Recent Developments and Future Plans
Table 10. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 11. Bio-Rad Laboratories Major Business
Table 12. Bio-Rad Laboratories Drug Abuse Screening Product and Solutions
Table 13. Bio-Rad Laboratories Drug Abuse Screening Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Bio-Rad Laboratories Recent Developments and Future Plans
Table 15. Clinical Reference Laboratory Company Information, Head Office, and Major Competitors
Table 16. Clinical Reference Laboratory Major Business
Table 17. Clinical Reference Laboratory Drug Abuse Screening Product and Solutions
Table 18. Clinical Reference Laboratory Drug Abuse Screening Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Laboratory Corporation of America Holdings Company Information, Head Office, and Major Competitors
Table 20. Laboratory Corporation of America Holdings Major Business
Table 21. Laboratory Corporation of America Holdings Drug Abuse Screening Product and Solutions
Table 22. Laboratory Corporation of America Holdings Drug Abuse Screening Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Laboratory Corporation of America Holdings Recent Developments and Future Plans
Table 24. Legacy Medical Services Company Information, Head Office, and Major Competitors
Table 25. Legacy Medical Services Major Business
Table 26. Legacy Medical Services Drug Abuse Screening Product and Solutions
Table 27. Legacy Medical Services Drug Abuse Screening Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Legacy Medical Services Recent Developments and Future Plans
Table 29. LGC Group Company Information, Head Office, and Major Competitors
Table 30. LGC Group Major Business
Table 31. LGC Group Drug Abuse Screening Product and Solutions
Table 32. LGC Group Drug Abuse Screening Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. LGC Group Recent Developments and Future Plans
Table 34. Mayo Clinic Laboratories Company Information, Head Office, and Major Competitors
Table 35. Mayo Clinic Laboratories Major Business
Table 36. Mayo Clinic Laboratories Drug Abuse Screening Product and Solutions
Table 37. Mayo Clinic Laboratories Drug Abuse Screening Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Mayo Clinic Laboratories Recent Developments and Future Plans
Table 39. Millennium Health Company Information, Head Office, and Major Competitors
Table 40. Millennium Health Major Business
Table 41. Millennium Health Drug Abuse Screening Product and Solutions
Table 42. Millennium Health Drug Abuse Screening Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Millennium Health Recent Developments and Future Plans
Table 44. Omega Laboratories Company Information, Head Office, and Major Competitors
Table 45. Omega Laboratories Major Business
Table 46. Omega Laboratories Drug Abuse Screening Product and Solutions
Table 47. Omega Laboratories Drug Abuse Screening Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Omega Laboratories Recent Developments and Future Plans
Table 49. Precision Diagnostics Company Information, Head Office, and Major Competitors
Table 50. Precision Diagnostics Major Business
Table 51. Precision Diagnostics Drug Abuse Screening Product and Solutions
Table 52. Precision Diagnostics Drug Abuse Screening Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Precision Diagnostics Recent Developments and Future Plans
Table 54. Psychemedics Company Information, Head Office, and Major Competitors
Table 55. Psychemedics Major Business
Table 56. Psychemedics Drug Abuse Screening Product and Solutions
Table 57. Psychemedics Drug Abuse Screening Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Psychemedics Recent Developments and Future Plans
Table 59. Quest Diagnostics Company Information, Head Office, and Major Competitors
Table 60. Quest Diagnostics Major Business
Table 61. Quest Diagnostics Drug Abuse Screening Product and Solutions
Table 62. Quest Diagnostics Drug Abuse Screening Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Quest Diagnostics Recent Developments and Future Plans
Table 64. Sonic Healthcare Company Information, Head Office, and Major Competitors
Table 65. Sonic Healthcare Major Business
Table 66. Sonic Healthcare Drug Abuse Screening Product and Solutions
Table 67. Sonic Healthcare Drug Abuse Screening Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Sonic Healthcare Recent Developments and Future Plans
Table 69. United States Drug Testing Laboratories Company Information, Head Office, and Major Competitors
Table 70. United States Drug Testing Laboratories Major Business
Table 71. United States Drug Testing Laboratories Drug Abuse Screening Product and Solutions
Table 72. United States Drug Testing Laboratories Drug Abuse Screening Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. United States Drug Testing Laboratories Recent Developments and Future Plans
Table 74. Global Drug Abuse Screening Revenue (USD Million) by Players (2020-2025)
Table 75. Global Drug Abuse Screening Revenue Share by Players (2020-2025)
Table 76. Breakdown of Drug Abuse Screening by Company Type (Tier 1, Tier 2, and Tier 3)
Table 77. Market Position of Players in Drug Abuse Screening, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 78. Head Office of Key Drug Abuse Screening Players
Table 79. Drug Abuse Screening Market: Company Product Type Footprint
Table 80. Drug Abuse Screening Market: Company Product Application Footprint
Table 81. Drug Abuse Screening New Market Entrants and Barriers to Market Entry
Table 82. Drug Abuse Screening Mergers, Acquisition, Agreements, and Collaborations
Table 83. Global Drug Abuse Screening Consumption Value (USD Million) by Type (2020-2025)
Table 84. Global Drug Abuse Screening Consumption Value Share by Type (2020-2025)
Table 85. Global Drug Abuse Screening Consumption Value Forecast by Type (2026-2031)
Table 86. Global Drug Abuse Screening Consumption Value by Application (2020-2025)
Table 87. Global Drug Abuse Screening Consumption Value Forecast by Application (2026-2031)
Table 88. North America Drug Abuse Screening Consumption Value by Type (2020-2025) & (USD Million)
Table 89. North America Drug Abuse Screening Consumption Value by Type (2026-2031) & (USD Million)
Table 90. North America Drug Abuse Screening Consumption Value by Application (2020-2025) & (USD Million)
Table 91. North America Drug Abuse Screening Consumption Value by Application (2026-2031) & (USD Million)
Table 92. North America Drug Abuse Screening Consumption Value by Country (2020-2025) & (USD Million)
Table 93. North America Drug Abuse Screening Consumption Value by Country (2026-2031) & (USD Million)
Table 94. Europe Drug Abuse Screening Consumption Value by Type (2020-2025) & (USD Million)
Table 95. Europe Drug Abuse Screening Consumption Value by Type (2026-2031) & (USD Million)
Table 96. Europe Drug Abuse Screening Consumption Value by Application (2020-2025) & (USD Million)
Table 97. Europe Drug Abuse Screening Consumption Value by Application (2026-2031) & (USD Million)
Table 98. Europe Drug Abuse Screening Consumption Value by Country (2020-2025) & (USD Million)
Table 99. Europe Drug Abuse Screening Consumption Value by Country (2026-2031) & (USD Million)
Table 100. Asia-Pacific Drug Abuse Screening Consumption Value by Type (2020-2025) & (USD Million)
Table 101. Asia-Pacific Drug Abuse Screening Consumption Value by Type (2026-2031) & (USD Million)
Table 102. Asia-Pacific Drug Abuse Screening Consumption Value by Application (2020-2025) & (USD Million)
Table 103. Asia-Pacific Drug Abuse Screening Consumption Value by Application (2026-2031) & (USD Million)
Table 104. Asia-Pacific Drug Abuse Screening Consumption Value by Region (2020-2025) & (USD Million)
Table 105. Asia-Pacific Drug Abuse Screening Consumption Value by Region (2026-2031) & (USD Million)
Table 106. South America Drug Abuse Screening Consumption Value by Type (2020-2025) & (USD Million)
Table 107. South America Drug Abuse Screening Consumption Value by Type (2026-2031) & (USD Million)
Table 108. South America Drug Abuse Screening Consumption Value by Application (2020-2025) & (USD Million)
Table 109. South America Drug Abuse Screening Consumption Value by Application (2026-2031) & (USD Million)
Table 110. South America Drug Abuse Screening Consumption Value by Country (2020-2025) & (USD Million)
Table 111. South America Drug Abuse Screening Consumption Value by Country (2026-2031) & (USD Million)
Table 112. Middle East & Africa Drug Abuse Screening Consumption Value by Type (2020-2025) & (USD Million)
Table 113. Middle East & Africa Drug Abuse Screening Consumption Value by Type (2026-2031) & (USD Million)
Table 114. Middle East & Africa Drug Abuse Screening Consumption Value by Application (2020-2025) & (USD Million)
Table 115. Middle East & Africa Drug Abuse Screening Consumption Value by Application (2026-2031) & (USD Million)
Table 116. Middle East & Africa Drug Abuse Screening Consumption Value by Country (2020-2025) & (USD Million)
Table 117. Middle East & Africa Drug Abuse Screening Consumption Value by Country (2026-2031) & (USD Million)
Table 118. Global Key Players of Drug Abuse Screening Upstream (Raw Materials)
Table 119. Global Drug Abuse Screening Typical Customers
LIST OF FIGURES
Figure 1. Drug Abuse Screening Picture
Figure 2. Global Drug Abuse Screening Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Drug Abuse Screening Consumption Value Market Share by Type in 2024
Figure 4. Urine Sample
Figure 5. Breath Sample
Figure 6. Oral Fluid Sample
Figure 7. Hair Sample
Figure 8. Global Drug Abuse Screening Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Drug Abuse Screening Consumption Value Market Share by Application in 2024
Figure 10. Drug Testing Laboratories Picture
Figure 11. Hospital Picture
Figure 12. Others Picture
Figure 13. Global Drug Abuse Screening Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global Drug Abuse Screening Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 15. Global Market Drug Abuse Screening Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 16. Global Drug Abuse Screening Consumption Value Market Share by Region (2020-2031)
Figure 17. Global Drug Abuse Screening Consumption Value Market Share by Region in 2024
Figure 18. North America Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 19. Europe Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 20. Asia-Pacific Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 21. South America Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 22. Middle East & Africa Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 23. Company Three Recent Developments and Future Plans
Figure 24. Global Drug Abuse Screening Revenue Share by Players in 2024
Figure 25. Drug Abuse Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 26. Market Share of Drug Abuse Screening by Player Revenue in 2024
Figure 27. Top 3 Drug Abuse Screening Players Market Share in 2024
Figure 28. Top 6 Drug Abuse Screening Players Market Share in 2024
Figure 29. Global Drug Abuse Screening Consumption Value Share by Type (2020-2025)
Figure 30. Global Drug Abuse Screening Market Share Forecast by Type (2026-2031)
Figure 31. Global Drug Abuse Screening Consumption Value Share by Application (2020-2025)
Figure 32. Global Drug Abuse Screening Market Share Forecast by Application (2026-2031)
Figure 33. North America Drug Abuse Screening Consumption Value Market Share by Type (2020-2031)
Figure 34. North America Drug Abuse Screening Consumption Value Market Share by Application (2020-2031)
Figure 35. North America Drug Abuse Screening Consumption Value Market Share by Country (2020-2031)
Figure 36. United States Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 37. Canada Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 38. Mexico Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 39. Europe Drug Abuse Screening Consumption Value Market Share by Type (2020-2031)
Figure 40. Europe Drug Abuse Screening Consumption Value Market Share by Application (2020-2031)
Figure 41. Europe Drug Abuse Screening Consumption Value Market Share by Country (2020-2031)
Figure 42. Germany Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 43. France Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 44. United Kingdom Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 45. Russia Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 46. Italy Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 47. Asia-Pacific Drug Abuse Screening Consumption Value Market Share by Type (2020-2031)
Figure 48. Asia-Pacific Drug Abuse Screening Consumption Value Market Share by Application (2020-2031)
Figure 49. Asia-Pacific Drug Abuse Screening Consumption Value Market Share by Region (2020-2031)
Figure 50. China Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 51. Japan Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 52. South Korea Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 53. India Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 54. Southeast Asia Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 55. Australia Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 56. South America Drug Abuse Screening Consumption Value Market Share by Type (2020-2031)
Figure 57. South America Drug Abuse Screening Consumption Value Market Share by Application (2020-2031)
Figure 58. South America Drug Abuse Screening Consumption Value Market Share by Country (2020-2031)
Figure 59. Brazil Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 60. Argentina Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 61. Middle East & Africa Drug Abuse Screening Consumption Value Market Share by Type (2020-2031)
Figure 62. Middle East & Africa Drug Abuse Screening Consumption Value Market Share by Application (2020-2031)
Figure 63. Middle East & Africa Drug Abuse Screening Consumption Value Market Share by Country (2020-2031)
Figure 64. Turkey Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 65. Saudi Arabia Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 66. UAE Drug Abuse Screening Consumption Value (2020-2031) & (USD Million)
Figure 67. Drug Abuse Screening Market Drivers
Figure 68. Drug Abuse Screening Market Restraints
Figure 69. Drug Abuse Screening Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Drug Abuse Screening Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
